会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • MR coronary angiography with a fluorinated nanoparticle contrast agent at 1.5 T
    • 用1.5 T的氟化纳米颗粒造影剂进行MR冠状动脉造影
    • US20060239919A1
    • 2006-10-26
    • US11367971
    • 2006-03-03
    • Samuel WicklineGregory Lanza
    • Samuel WicklineGregory Lanza
    • A61B5/055
    • B82Y5/00A61K49/1806
    • Disclosed herein is a medical imaging technique that uses a fluorinated nanoparticle contrast agent for imaging of an interior portion of a body. The fluorinated nanoparticles preferably comprise nontargeted intravascular fluorocarbon or perfluorocarbon nanoparticles. The interior body portion may be a patient's vasculature, and the medical imaging is preferably noninvasive MR angiography, which may encompass (either for 2D imaging or 3D imaging) MR coronary angiography, MR carotid angiography, MR peripheral angiography, MR cerebral angiography, MR arterial angiography, and MR venous angiography. Coils tuned to match to the 19F signal can be used, or dual tuned coils for 19F and 1H imaging can be used. Clinical field strengths (e.g. 1.5 T) and clinical doses may be used while still providing effective images.
    • 本文公开了一种医疗成像技术,其使用氟化纳米颗粒造影剂来成像身体的内部部分。 氟化纳米颗粒优选包含非靶向的血管内碳氟化合物或全氟化碳纳米颗粒。 内部主体部分可以是患者的脉管系统,并且医学成像优选是非侵入性MR血管造影术,其可以包括(用于2D成像或3D成像)MR冠状动脉造影,MR颈动脉血管造影术,MR周围血管造影术,MR脑血管造影术,MR动脉 血管造影和MR静脉血管造影。 可以使用调谐到与 19F信号相匹配的线圈,或者可以使用用于<20> F和<1> H / H成像的双调谐线圈。 可以在仍然提供有效图像的同时使用临床场强(例如1.5T)和临床剂量。
    • 10. 发明申请
    • Detection and imaging of target tissue
    • 目标组织的检测和成像
    • US20070258908A1
    • 2007-11-08
    • US11796415
    • 2007-04-27
    • Gregory LanzaSamuel Wickline
    • Gregory LanzaSamuel Wickline
    • A61K49/10
    • A61K49/1809A61K49/0041A61K49/0082A61K49/0093A61K51/122
    • Methods for high resolution imaging of a suspected target tissue are encompassed by the invention. Such methods include administering low resolution and high resolution contrast agents specific to targeted cells or tissues. The contrast agents are allowed to bind to the target cells or accumulate in a target tissue. A low resolution imaging technique is used to localize an accumulation of the low resolution contrast agent in a target tissue. A high resolution image of the target tissue is then obtained to localize an accumulation of the higher resolution contrast agent, allowing the generation of a higher resolution image than that obtained by the use of the low resolution contrast agent alone. These methods may utilize nanoparticles optionally in an emulsion as a contrast agent.
    • 本发明涉及可疑目标组织的高分辨率成像方法。 这样的方法包括施用对靶细胞或组织特异的低分辨率和高分辨率造影剂。 使造影剂与靶细胞结合或聚集在靶组织中。 低分辨率成像技术用于定位目标组织中低分辨率造影剂的积聚。 然后获得目标组织的高分辨率图像以定位较高分辨率造影剂的累积,允许产生比通过仅使用低分辨率造影剂获得的更高分辨率图像。 这些方法可以任选地使用乳剂中的纳米颗粒作为造影剂。